Lurasidone Hydrochloride CAS 367514-88-3 Purity ≥99.0% (HPLC) API
Chemical Name | Lurasidone Hydrochloride |
Synonyms | Lurasidone HCl; Latuda; SM-13496 Hydrochloride; (3aR,4R,7R,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl) methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione Hydrochloride |
CAS Number | 367514-88-3 |
Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
Molecular Formula | C28H36N4O2S |
Molecular Weight | 492.684 |
Melting Point | 198.0~205.0°C |
Shipping Condition | Shipped Under Ambient Temperature |
COA & MSDS | Available |
Place of Origin | Shanghai, China |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White or Off-White Crystalline Powder |
NMR Spectrum 1H | Consistent with Structure |
Solubility | Meets the Requirements |
Max. Single Impurity | ≤0.20% |
Total Impurities | ≤0.50% |
Moisture (K.F) | ≤1.00% |
Residue of Ignition | ≤0.20% |
Heavy Metals | ≤20ppm |
Purity (HPLC Area) | ≥99.0% |
Test Standard | Enterprise Standard |
Usage | API, Atypical Antipsychotic Drug (AAPD) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
Risk Codes R11 - Highly Flammable
R23/24/25 - Toxic by inhalation, in contact with skin and if swallowed.
R39/23/24/25 -
Safety Description S7 - Keep container tightly closed.
S16 - Keep away from sources of ignition.
S36/37 - Wear suitable protective clothing and gloves.
S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
UN IDs UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany 1
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lurasidone Hydrochloride (CAS 367514-88-3) with high quality, API.
Lurasidone Hydrochloride (CAS 367514-88-3) is an orally administered substance that belongs to the class of atypical antipsychotic drugs (AAPD), developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States. It received approval by the EMA in 2014 for schizophrenia. Lurasidone has also been launched in a number of countries outside the US and EU, including Canada, where it is approved for both indications. It is produced through a multi-step chemical process.